tiprankstipranks
Trending News
More News >
Newron Pharmaceuticals SpA (CH:NWRN)
:NWRN
Switzerland Market
Advertisement

Newron Pharmaceuticals SpA (NWRN) Stock Forecast & Price Target

Compare
0 Followers
See the Price Targets and Ratings of:

NWRN Financial Forecast

No data currently available

NWRN Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.
No data currently available

NWRN Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on CH:NWRN
TipRanks AITipRanks
Not Ranked
TipRanks
CHF7.5
Hold
10.46%
Upside
Reiterated
06/13/25
Newron Pharmaceuticals SpA's score is driven primarily by strong revenue growth and profitability but is offset by concerns regarding leverage and negative cash flows. The technical analysis suggests neutral market sentiment, while the valuation is reasonable, reflecting balanced growth prospects and financial risks.
AI Firm
CHF8.5CHF7.5
Hold
10.46%
Upside
Reiterated
06/13/25
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on CH:NWRN
TipRanks AITipRanks
Not Ranked
TipRanks
CHF7.5
Hold
10.46%
Upside
Reiterated
06/13/25
Newron Pharmaceuticals SpA's score is driven primarily by strong revenue growth and profitability but is offset by concerns regarding leverage and negative cash flows. The technical analysis suggests neutral market sentiment, while the valuation is reasonable, reflecting balanced growth prospects and financial risks.
AI Firm
CHF8.5CHF7.5
Hold
10.46%
Upside
Reiterated
06/13/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

NWRN Analyst Recommendation Trends

Rating
Dec 21
Mar 23
Feb 24
Jun 25
Strong Buy
0
1
2
2
Buy
0
0
0
0
Hold
1
1
1
1
Sell
0
0
0
0
Strong Sell
0
0
0
0
total
1
2
3
3
In the current month, NWRN has received 2 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. NWRN average Analyst price target in the past 3 months is 7.50.
Each month's total comprises the sum of three months' worth of ratings.

NWRN Stock Forecast FAQ

What is CH:NWRN’s average 12-month price target, according to analysts?
Based on analyst ratings, Newron Pharmaceuticals SpA’s 12-month average price target is 7.50.
    What is CH:NWRN’s upside potential, based on the analysts’ average price target?
    Newron Pharmaceuticals SpA has 10.47% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Newron Pharmaceuticals SpA a Buy, Sell or Hold?
          Newron Pharmaceuticals SpA has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Newron Pharmaceuticals SpA’s share price target?
            The average share price target for Newron Pharmaceuticals SpA is 7.50. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is CHF7.50 ,and the lowest forecast is CHF7.50. The average share price target represents 10.47% Increase from the current price of CHF6.79.
              What do analysts say about Newron Pharmaceuticals SpA?
              Newron Pharmaceuticals SpA’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of Newron Pharmaceuticals SpA?
                To buy shares of CH:NWRN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis